<p>Thrombosis remains a leading cause of morbidity and mortality in paroxysmal nocturnal hemoglobinuria (PNH). Complement inhibitors are the cornerstone of treatment for PNH, significantly lowering the risk of thrombotic events. As noted by our experts in today’s podcast, anticoagulation continues to play a critical role, particularly in the secondary prevention and management of acute thrombosis.</p> <p> </p> <p><iframe title="Expert Perspectives® in PNH Podcast 2025" width="500" height="281" src="https://www.youtube.com/embed/pnv4N7VVqW0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></p>